株式会社極東書店トップ商品一覧Bloody Bioethics : Why Prohibiting Plasma Compensation Harms Patients and Wrongs Donors.

商品詳細

Bloody Bioethics

Bloody Bioethics : Why Prohibiting Plasma Compensation Harms Patients and Wrongs Donors.

・ISBN 978-1-032-20386-7 2022 hard GB£ 120.00

¥38,016.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り

・ISBN 978-1-032-20505-2 2024 paper GB£ 43.99

¥13,935.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り

電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 978-1-003-26391-3

著者・編者Taylor, James Stacey,
シリーズRoutledge Annals of Bioethics
出版社(Routledge, UK)
出版年月2022.03
ページ数188 pp.
言語ENG
ニュース番号<669-134 669-695>

解説

This is the first book to argue in favor of paying people for their blood plasma. It does not merely argue that offering compensation to plasma donors is morally permissible. It argues that prohibiting donor compensation is morally wrong-and that it is morally wrong for all of the reasons that are offered against allowing donor compensation.

Opponents of donor compensation claim that it will reduce the amount and quality of plasma obtained, exploit and coerce donors, and undermine social cohesion. James Stacey Taylor argues that empirical evidence demonstrates that compensating plasma donors greatly increases the amount of plasma obtained with no adverse effects on the quality of the pharmaceutical products that are manufactured from it. Prohibiting compensation thus harms patients by reducing their access to the medicines they need. He also argues that it is the prohibition of compensation-not its offer-that exploits donors, fails to respect the moral need to secure a person's authoritative consent to her treatment, and prevents donors from giving their informed consent to donate. Prohibiting compensation thus not only harms patients but also wrongs donors.

Bloody Bioethics will appeal to researchers, advanced students, and medical professionals interested in bioethics, moral philosophy, and the moral limits of markets.